.
 
.

Economics of New Health Technologies

.
Redna cena: 81,42 €
Predvideni rok dobave: 14-21 dni
.
.
Količina:  
.
Strošek dostave je enoten za celo Slovenijo in znaša 2,95 €, ne glede na količino in vrsto kupljenih izdelkov.

Številni izdelki imajo oznako "brezplačna dostava", kar pomeni, da v prmeru nakupa takšnega izdelka poštnine ne boste plačali. 

Več o dostavi
Emka.si omogoča naslednje načine plačila:
  • z gotovino ob prevzemu (velja le za fizične osebe),
  • s plačilno oziroma kreditno kartico (Mastercard, Visa, ActivaMaestro, Activa, Diners, American Express),
  • s storitvijo Moneta (Mobitel in Simobil)
  • Plačilo po predračunu (pravne osebe)
  • Račun z odlogom plačila (za javna podjetja)
Več o plačilih

Pri vsakem izdelku je naveden predviden rok dostave. Glede na to katere izdelke izberete, se vam pri oddaji naročila prikaže tudi končni predviden datum dobave vašega pakete.

Večino izdelkov dostavljamo iz lastne zaloge, zato so naši dobavni roki zelo kratki.

Ko vam bomo poslali paket boste o tem obveščeni tudi po emailu. V emailu bo navedena številka vašega paketa ter povezava do Pošte Slovenije, kjer boste lahko preverili natančen status dostave.

Več o dostavi

To je spletna cena
Shrani v seznam želja
.

.

Opis

Incentives, Organization, and Financing

Technological change in healthcare has led to huge improvements in health services and the health status of populations. Although offering remarkable benefits, these changes often entail significant financial, physical and social risks. This book analyses the impact of advances in medical technology from an economic perspective.

Technological change in healthcare has led to huge improvements in health services and the health status of populations. It is also pinpointed as the main driver of healthcare expenditure. Although offering remarkable benefits, changes in technology are not free and often entail significant financial, as well as physical or social risks. These need to be balanced out in the setting of government regulations, insurance contracts, and individuals' decisions to use and consume certain technologies. With this in mind, this book addresses the following important objectives: to provide a detailed analysis of what technological change is; to identify drivers of innovation in several healthcare areas; to present existing mechanisms and processes for ensuring and valuing efficiency and development in the use of medical technologies; and to analyse the impact of advances in medical technology on health, healthcare expenditure, and health insurance.; Each of the seventeen chapters summarizes an important issue concerning the innovation debate and contributes to a better understanding of the role innovation has both at the macro level and at the delivery (meso) and micro level in the healthcare sector. The effectiveness of innovation in improving people's welfare depends on its diffusion and inception by the relevant agents in the health production process, and this book recognizes the multi-faceted contribution of policy makers, regulators, managers, technicians, consumers and patients to this technology change. This book offers the first truly global economic analysis of healthcare technologies, taking the subject beyond simply economic evaluation, and exploring the behavioural aspects, organization and incentives for new technology developments, and the adoption and diffusion of these technologies.

PART I. INTRODUCTION; 1. What do we know about the role of health care technology in driving healthcare expenditure growth?; PART II. INNOVATION, DIFFUSION AND TECHNOLOGY CHANGE; 2. The process of innovation: incentives, behaviour and organization; 3. Technology - scientific force or power force?; 4. Diffusion of health technologies: evidence from the pharmaceutical sector; PART III. TECHNOLOGICAL CHANGE AND HEALTH INSURANCE; 5. Insurance and new health technology; 6. Technological change and health insurance; 7. Health insurance and the uptake of new drugs in the United States; 8. Genetic advances and health insurance; PART IV. INNOVATION, SOCIAL DEMAND AND VALUATION; 9. Ageing and pharmaceutical innovation; 10. New approaches to healthcare innovation: information for chronic patients; 11. The convergence of nano-, bio- and information technologies in healthcare; 12. Treatment uncertainty and irreversibility in medical care: implications for cost-effectiveness analysis; 13. The limits and challenges to the economic evaluation of health technologies; PART V. INCENTIVES, MECHANISMS AND PROCESSES; 14. Intellectual property rights and pharmaceuticals development; 15. Home, or nursing home? The effect of medical innovation on the demand for long-term care; 16. Demand for health information on the internet; 17. Institutional pathways for integrating genetic testing into mainstream healthcare
.
.
Oglejte si ostale knjige tega avtorja
.
.
Oglejte si vse knjige tega avtorja
.

O avtorju - Joan Costa-Font

Obvestite me o novi knjigi tega avtorja

Želite, da vas po elektronski pošti obvestimo, ko izide nova knjiga ali ponatis katere od knjig tega avtorja?

DA - obveščajte me o novostih avtorja
.
.
.
.

Podrobnosti o izdelku

  • Obseg/št. strani: 312
  • Datum Izida:
  • Jezik: angleški
  • Vezava: Mehka
  • ISBN/EAN: 9780199550685
  • Mere izdelka vxš: 23,4 x 15,6 cm
  • Založba Oxford University Press
  • Avtor:
  • Povprečna ocena:
    Ocena kupcev: 0
    (0)

Mnenja kupcev

  0  ocen:
5 zvezdice
0%
(0)
4 zvezdice
0%
(0)
3 zvezdice
0%
(0)
2 zvezdice
0%
(0)
1 zvezdica
0%
(0)
Povprečna ocena kupcev:
Ocena kupcev: 0
(0 ocen uporabnikov )
.
Ocenite izdelek s klikom na zvezdice:
 
.
.
.
.
.

Oznake kupcev o tem izdelku

Kliknite na posamezno oznako za prikaz vseh izdelkov označenih s to oznako:

Dodaj oznako:

Dodaj
.